Yahoo India Web Search

Search results

1. Top stories

   • 

     AstraZeneca India to expand Chennai Global Innovation and Technology Centre with Rs 250 crore investment

     Chennai: AstraZeneca India Private Limited, the Global Capability Centre (GCC) of AstraZeneca, has announced an investment of 250 crore rupees to expand its Global Innovation and Technology Centre (GITC) in Chennai, Tamil Nadu, which includes close to ...

     Daily

     29 minutes ago

   • 

     Indiatimes

     AstraZeneca expands its Chennai office

     2 days ago

   • 

     health.economictimes.indiatimes

     AstraZeneca India to invest Rs 250 crore to expand its Global Innovation and Technology Centre

     3 days ago

   • 

     The Hindu

     AstraZeneca to invest ₹250 crore to expand its global innovation and technology centre in Chennai

     3 days ago

   • Indiatimes on MSN.com

     AstraZeneca expands its Chennai office, making its biggest GCC globally

     3 days ago

   View all

2. www.astrazeneca.comAstraZeneca - Research-Based BioPharmaceutical Company

   www.astrazeneca.com

   • Cached

   AstraZeneca is a global, science-led biopharmaceutical business and our innovative medicines are used by millions of patients worldwide.

   • Careers

     Life at AstraZeneca. We’re curious about science and the...

   • Investor Relations

     Investor Relations - AstraZeneca - Research-Based...

   • What science can do

     What science can do - AstraZeneca - Research-Based...

   • R&D

     Any reference in these archives to AstraZeneca products or...

   • Our therapy areas

     CVRM (Cardiovascular, Renal and Metabolism) is one of our...

   • Our company

     Our company. We are a global, science-led, patient-focused...

   • Media

     Media - AstraZeneca - Research-Based BioPharmaceutical...

   • Sustainability

     We are focused on accelerating the delivery of life-changing...

3. en.wikipedia.org › wiki › AstraZenecaAstraZeneca - Wikipedia

   en.wikipedia.org › wiki › AstraZeneca

   • Cached

   AstraZeneca's primary listing is on the London Stock Exchange and is a constituent of the FTSE 100 Index; it also has a secondary listing on the Nasdaq Stockholm. AstraZeneca has one of the highest market capitalisations of pharmaceutical companies worldwide.

4. www.astrazeneca.com › our-companyAbout Our Company - AstraZeneca

   www.astrazeneca.com › our-company

   • Cached

   Our company. We are a global, science-led, patient-focused pharmaceutical company. We are dedicated to transforming the future of healthcare by unlocking the power of what science can do for people, society and the planet.

5. careers.astrazeneca.comWorking at AstraZeneca

   careers.astrazeneca.com

   • Cached

   Life at AstraZeneca. We’re curious about science and the advancement of knowledge. We find creative ways to approach new challenges. We’re driven to make the right choices and be accountable for our actions. As an organisation centred around what makes us human, we put a big focus on people.

   • 
   • 
   • 
   • 

6. Images

   • 
   • 
   • 

   View all

7. www.astrazeneca.inAstraZeneca India - Research-Based BioPharmaceutical Company

   www.astrazeneca.in

   • Cached

   At AstraZeneca we’re united by our desire to push the boundaries of science to deliver life-changing medicines. We know it’s how we will continue to transform the lives of millions of patients around the world while delivering value to our employees, our communities, and the environment.

   • 
   • 
   • 
   • 

8. www.who.int › news-room › feature-storiesThe Oxford/AstraZeneca (ChAdOx1-S [recombinant] vaccine ...

   www.who.int › news-room › feature-stories

   • Cached

   Jun 13, 2022 · The AstraZeneca vaccine has an efficacy of 72% against symptomatic SARS-CoV-2 infection, as shown by the primary analysis of data irrespective of interdose interval from trial participants who received 2 standard doses with an interval varying from about 4 to 12 weeks.

9. www.astrazeneca.com › media-centre › press-releasesCOVID-19 Vaccine AstraZeneca confirms 100% protection against ...

   www.astrazeneca.com › media-centre › press-releases

   • Cached

   Feb 3, 2021 · COVID-19 Vaccine AstraZeneca confirms 100% protection against severe disease, hospitalisation and death in the primary analysis of Phase III trials. 3 February 2021 07:00 GMT. The primary analysis of the Phase III clinical trials from the UK, Brazil and South Africa, published as a preprint in The Lancet confirmed COVID-19 Vaccine AstraZeneca ...

10. People also ask

    What does AstraZeneca do?

    • At AstraZeneca, we’re committed to diving deep into the root cause of heart failure to determine the changes we need to make in ways we treat this disease, transform care and ultimately improve outcomes. AstraZeneca is a global, science-led biopharmaceutical business and our innovative medicines are used by millions of patients worldwide.

    AstraZeneca - Research-Based BioPharmaceutical Company

    www.astrazeneca.com/

    See all results for this question

    What makes AstraZeneca a sustainable company?

    • At AstraZeneca, sustainability is part of our DNA, embedded in everything we do, from the lab to the patient. Working in partnership with all our stakeholders, we are harnessing the power of science and innovation to deliver life-changing medicines in a way that is respectful of our planet.

    About Our Company - AstraZeneca

    www.astrazeneca.com/our-company.html

    See all results for this question

    What happened to AstraZeneca?

    • In February 2018, AstraZeneca announced it was spinning off six early-stage experimental drugs into a new biotechnology company, known as Viela Bio, valued at US$250 million. On 6 December 2018, AstraZeneca purchased nearly 8% of the American pharmaceutical business, Moderna.

    AstraZeneca - Wikipedia

    en.wikipedia.org/wiki/AstraZeneca

    See all results for this question

    Where is AstraZeneca headquartered?

    • AstraZeneca India was established in 1979 and is headquartered at Bengaluru, Karnataka. AstraZeneca Pharma India Limited (AZPIL) is the operating company and covers manufacturing, sales and marketing activities of the company in India. It is a listed company and is a subsidiary of AstraZeneca Plc, UK.

    AstraZeneca India - Research-Based BioPharmaceutical Company

    www.astrazeneca.in/

    See all results for this question